Bupivacaine enhances the magnitude and longevity of HIV-specific immune response after immunization with a CD4 epitope-based DNA vaccine (2014)
- Authors:
- USP affiliated authors: CUNHA NETO, EDECIO - FM ; KALIL FILHO, JORGE ELIAS - FM
- Unidade: FM
- DOI: 10.1016/j.trivac.2014.05.001
- Subjects: ANESTÉSICOS; HIIV; IMUNOLOGIA; EPITOPOS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Trials in Vaccinology
- ISSN: 1879-4378
- Volume/Número/Paginação/Ano: v. 3, p. 95-101, 2014
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc-nd
-
ABNT
RIBEIRO, Susan Pereira et al. Bupivacaine enhances the magnitude and longevity of HIV-specific immune response after immunization with a CD4 epitope-based DNA vaccine. Trials in Vaccinology, v. 3, p. 95-101, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.trivac.2014.05.001. Acesso em: 18 abr. 2024. -
APA
Ribeiro, S. P., Apostólico, J. de S., Almeida, R. R., Kalil, J., & Cunha-Neto, E. (2014). Bupivacaine enhances the magnitude and longevity of HIV-specific immune response after immunization with a CD4 epitope-based DNA vaccine. Trials in Vaccinology, 3, 95-101. doi:10.1016/j.trivac.2014.05.001 -
NLM
Ribeiro SP, Apostólico J de S, Almeida RR, Kalil J, Cunha-Neto E. Bupivacaine enhances the magnitude and longevity of HIV-specific immune response after immunization with a CD4 epitope-based DNA vaccine [Internet]. Trials in Vaccinology. 2014 ; 3 95-101.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1016/j.trivac.2014.05.001 -
Vancouver
Ribeiro SP, Apostólico J de S, Almeida RR, Kalil J, Cunha-Neto E. Bupivacaine enhances the magnitude and longevity of HIV-specific immune response after immunization with a CD4 epitope-based DNA vaccine [Internet]. Trials in Vaccinology. 2014 ; 3 95-101.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1016/j.trivac.2014.05.001 - T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain
- Novas estratégias de vacinas
- HIV CD4 based vaccine increases CD8 cell responses andconfers protection against challenge with recombinant vaccinia enconding HIV gag-pol proteins
- Protease inhibitors-induced mutations do not impair the in silico binding prediction of HIV-1 protease sequences to HLA-DR molecules
- Novel HIV-1 multiepitopic and multiallelic vaccine formulations elicit strong CD4+ and CD8+ immune responses in BALB/C and HLA class-II transgenic mice
- Immunogenecity of a DNA vaccine containing multiple HLA-DR binding, conserved M group HIV-1 epitopes in Balc/C mice
- Polymorphisms in genes affecting interferon-gamma production and Th1 T Cell differentiation are associated with progression to chagas disease cardiomyopathy (vol 11, 1386, 2020)
- Locally produced survival cytokines IL-15 and IL-7 may be associated to the predominance of CD8+ T cells at heart lesions of human chronic Chagas disease cardiomyopathy
- An Immunodominant Region of Streptococcal M Protein is Recognized by Peripheral and Intralesional T Cells of Rheumatic Heart Disease Patients
- Mycobacterium tuberculosis epitope-specific interferon-g production in healthy Brazilians reactive and non-reactive to tuberculin skin test
Informações sobre o DOI: 10.1016/j.trivac.2014.05.001 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
